Search Results for:
-
MARRIAGES CAN BENEFIT BOTH PARTNERS
The large, well-established conglomerates found the means to establish or strengthen their presence in biotechnology, and the more mature biotech companies found a source of cash to help them get to marketBioWorld Today | Monday, January 25, 1993 -
DNAP LICENSES CHITINASE PATENT
The license gives Mogen, a plant biotech company that has close ties with seed companies, the exclusive worldwide rights to commercialize the patent for all applications to all crops except in DNAP's key business areas, principally premium fruits and vegetables and edible canola oilBioWorld Today | Wednesday, January 20, 1993 -
LETTER TO PRESIDENT CLINTON
Also on the wish list for the first 100 days: -- Enact the Biotechnology Patent Protection Act, to prevent foreign companies from exporting U.S.-patented products to the U.S. -- Support appropriations that would allow FDA to collect user fees and to hire new staff to speed drug approval. -- For the longer term, the two trade chiefs said that certain corporate accounting rules must be changed to enable emerging biotech companies to use stock options to attract scientist and managers...biotechBioWorld Today | Monday, January 11, 1993 -
ABC MERGES WITH IBA TO FORM BIO
The merged organization will ably represent each constituency, ranging from multinational heath care companies down to one- to two-person emerging biotech companies," said Sayare. -- David C. Holzman Special to BioWorld (c) 1997 American Health ConsultantsBioWorld Today | Monday, January 11, 1993 -
INDUSTRY LEADER SEES CONSOLIDATION IN '90S
Here are verbatim excerpts: There are some 1,100 biotech companies in the total industry, of which 200 are publicBioWorld Today | Friday, January 8, 1993 -
CELL GENESYS REVIVES IPO
To date, Cell Genesys has attracted about $25 million in private equity funding and a number of research collaborations with other biotech companiesBioWorld Today | Tuesday, January 5, 1993 -
SANDOZ INCREASES STAKE IN REPLIGEN
has bought out Repligen's interest in their joint venture and purchased $4 million of common stock in the Cambridge, Mass., biotech company (NASDAQ:RGENBioWorld Today | Tuesday, January 5, 1993 -
FDA APPROVES ORPHAN DRUG REGULATIONS
One biotech company representative, who requested anonymity, said the regulations governing what constitutes a "same drug" as one already marketed are virtually identical to interim regulationsBioWorld Today | Thursday, December 31, 1992 -
NIH SEEKS CRADA PROPOSALS
The Department of Health and Human Services (HHS) is seeking technology licensing and cooperative research and development agreement (CRADA) proposals from pharmaceutical or biotech companies for stabilizing nitric oxide compound technology developed by Larry Keefer of the National Cancer Institute (NCIBioWorld Today | Thursday, December 10, 1992 -
EDF HAILS CALL FOR FOOD LABELING
But the EDF feels that "FDA's policy sacrifices consumer protection by relying on biotech companies to police themselves," Hopkins saidBioWorld Today | Monday, November 23, 1992 -
AIS TO BUILD CELL THERAPY CENTER IN ISRAEL
This will set us apart from other biotech companies that are developing cell-based therapies," Ford saidBioWorld Today | Tuesday, November 17, 1992 -
ANTIBODY PROTECTS AGAINST REPERFUSION
Selectins as therapeutic targets are of interest to many pharmaceutical and biotech companiesBioWorld Today | Tuesday, November 17, 1992 -
INDUSTRY POLL MIXED ON CLINTON REGIME
Steven Burrill, national director of manufacturing and high- technology industry services for Ernst & Young, has mixed feelings about how the change in the White House will affect biotech companiesBioWorld Today | Tuesday, November 10, 1992 -
LILLY LOOKS TO BIOTECH
Part of this loss can be attributed to strategic alliances with other drug companies, including biotech companiesBioWorld Today | Wednesday, November 4, 1992 -
IMUTEC RAISES $4 MILLION
This gives the Scarborough, Ontario, biotech company about $7.25 million in working capitalBioWorld Today | Tuesday, November 3, 1992 -
SCIOS NOVA REACQUIRES SURFACTANT
John Lewicki, Scios Nova's vice president for research, told BioWorld that Genentech was originally chosen by Scios (then California Biotechnology Inc.) as its licensing partner in what may have been the first licensing deal between two biotech companiesBioWorld Today | Tuesday, November 3, 1992 -
ENVIROGEN COMPLETES FIRST TEST PHASE
The Lawrenceville, N.J., environmental biotech company (NASDAQ:ENVG) is testing the ability of its biocatalyst-reactor system, which contains a pure culture of TCE-degrading microbes to degrade TCE-contaminated air streamsBioWorld Today | Monday, November 2, 1992 -
USDA PROPOSES EASING BIOTECH REGULATIONS
Nonetheless, biotech companies and their industry associations praised the USDA's proposalsBioWorld Today | Monday, November 2, 1992 -
DNX EXPANDS TESTING SERVICES WITH ACQUISITION
Biotech companies want to do all the preclinical testing in one place...Pharmakon has ongoing contracts with about 70 biotech companies right now -- up from 40 last yearBioWorld Today | Thursday, October 29, 1992 -
RAGGIO COLLABORATION WITH JEFFERSON U.
The four-year, $1.5 million deal gives the Italian biotech company exclusive worldwide rights to "several patent applications being filed on peptide synthesis and disease research," the company saidBioWorld Today | Thursday, October 29, 1992
Category
Current Filters
- xbiotech companies
Related Keywords
Categories
- x BioWorld Today (1317)
- x BioWorld Insight (935)
- x BioWorld International (362)
- x Bio Perspectives (123)
- x State of the Industry Report (110)
- x BioWorld Snapshots (19)
- x Top 25 Drug Report (16)
- x BioWorld Genomics Review (12)
- x Recorded (5)
- x Executive Compensation Report (4)
- x RNAi Report (3)
- x Market-Leading Biotech Drugs (1)
- x Featured (1)
- x Biotech Innovations (1)
BioWorld | 3525 Piedmont Road
Building 6, Suite 400 | Atlanta, Georgia 30305, USA
Building 6, Suite 400 | Atlanta, Georgia 30305, USA
Part of Thompson Media Group LLC
Free Ezine
Sign up for Perspectives FREE e-mail newsletter.
Customer Service: In the U.S. and Canada: 1-800-477-6307
Outside the U.S.: 1-404-262-5423
customerservice@bioworld.com
Hours: Monday - Thursday, 8:30 am - 6:00 pm EST
Friday, 8:30am - 4:30 pm EST
Outside the U.S.: 1-404-262-5423
customerservice@bioworld.com
Hours: Monday - Thursday, 8:30 am - 6:00 pm EST
Friday, 8:30am - 4:30 pm EST
Copyright @ 2013 AHC Media. Reproduction, reposting content is strictly prohibited.